BOSTON—Biofourmis, a global technology-enabled care delivery company, announced the launch of its in-home services solution. The new functionality is the catalyst for an ecosystem of in-home service partners that aims to improve care delivery in the home by enabling patients to receive needed care sooner while improving efficiencies for clinicians.
From within the Biofourmis platform, providers can now order, schedule, confirm and track a comprehensive range of in-home services and diagnostics such as nursing, phlebotomy, infusion, durable medical equipment (DME), imaging—on-demand. The functionality supports Biofourmis Care solutions as well as digital clinical trials solution Biofourmis Connect.
The platform-enabled in-home services ecosystem provides:
- Integrated workflows for more efficient operations
- Biofourmis-managed services for less program overhead
- A la carte models to fit each customer's needs
- A focus on continuity of care for improved patient experience
"The idea for this innovative in-home services ecosystem came from listening to our health care and biopharma clients, who told us they could more easily launch and scale their care-at-home and digital clinical programs if they had on-demand access to in-home services from a curated network of trusted providers," said Maulik Majmudar, MD, chief medical officer and co-founder of Biofourmis. "With flexibility and scalability in mind, our customers can access Biofourmis-vetted service providers, or they can take a hybrid approach in which they onboard some of their own local service providers where they already have existing networks. We will continue to curate and validate our ecosystem based on market need and feedback."
